Who is sponsoring NCT03166514?

NCT03166514 is sponsored by Texas A&M University.

What drugs are being tested in NCT03166514?

Interventions in NCT03166514: Commercially Available Food Bar, Placebo.

What condition does NCT03166514 study?

NCT03166514 studies Glucose and Insulin Response.

Is NCT03166514 still recruiting?

NCT03166514 is currently completed. Last updated 13 April 2020.

Last reviewed 2020-04-13 · How we verify

NCT03166514: NB16

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Glycemic Response of a Commercial Food Bar

Completed NA Last updated 13 April 2020

What this trial tests

NA trial testing Commercially Available Food Bar in Glucose and Insulin Response in 20 participants. Completed in 1 May 2017.

Timeline

1 January 2017

Primary endpoint
1 May 2017

1 May 2017

Quick facts

Lead sponsor	Texas A&M University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	health services research
Enrollment	20
Start date	1 January 2017
Primary completion	1 May 2017
Estimated completion	1 May 2017

Drugs / interventions tested

Commercially Available Food Bar
Placebo

Conditions studied

Glucose and Insulin Response — all drugs for Glucose and Insulin Response →

Sponsor

Texas A&M University

Who can join

Adults 18 to 35, any sex, with Glucose and Insulin Response. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine the glucose and insulin response to a food bar.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Commercially Available Food Bar

Trials testing the same drug.

NCT03704337 — Effects Of Ingesting An Energy Bar On Performance And Recovery · NA · completed

Other Texas A&M University trials

Trials by the same sponsor.

NCT07079995 — Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial · NA · recruiting
NCT06950775 — The Neighborhood & Health Study · recruiting
NCT06890689 — Effectiveness of Scaling and Root Planing in Deeper Pockets · active not recruiting
NCT06797089 — Does myTAP Oral Appliance Therapy Including a Mouth Shield Lessen Periodontitis in Mouth-Breathers Who Snore? · NA · completed
NCT05959434 — Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03166514 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Texas A&M University
Last refreshed: 13 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03166514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing